RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2016 /PRNewswire/ -- bioMONTR Labs announced today they have entered into new MasterService Agreements to provide HIV-1 viral load testing services for CytoDyn's ongoing Phase 2b PRO 140 Monotherapy Extension Study and their upcoming Phase 3 PRO 140 Monotherapy Study.
Logo - http://photos.prnewswire.com/prnh/20161013/428641LOGO
Financial terms were not disclosed.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomontr-labs-to-provide-testing-services-for-cytodyn-pro-140-clinical-trials-300344770.html
SOURCE bioMONTR Labs
Subscribe to our Free Newsletters!